# Diabetes Drugs Ref

> Medical

Canonical page: [https://chrome-stats.com/d/id6761283169](https://chrome-stats.com/d/id6761283169)

## Overview

- **ID:** `id6761283169`
- **Platform:** Apple
- **Type:** Apple app
- **Status:** Available
- **Publisher:** ATIF ELNIL
- **Category:** Medical
- **Version:** 1.0.1
- **Last updated:** 2026-05-11
- **First published:** 2026-04-01
- **Size:** 18 MB
- **Data as of:** 2026-09-12
- **Store listing:** [Apple App Store](https://apps.apple.com/us/app/diabetes-drugs-ref/id6761283169)
- **Privacy policy:** [https://msdmt-privacy.tiiny.site](https://msdmt-privacy.tiiny.site/)

## Description

SGLT2 Inhibitors free. Subscribe to unlock all 9 drug classes — GLP-1, DPP-4, insulin, metformin, sulfonylureas — plus CV trials, sick day rule. NICE NG28 · ADA 2024.

Diabetes Drugs Reference — evidence-based pharmacology reference for diabetes drug classes. Based on NICE NG28 2022, ADA Standards of Care 2024, and SIGN 154.
FREE — no purchase needed:
— SGLT2 Inhibitors: empagliflozin, dapagliflozin, canagliflozin, ertugliflozin with doses, CV outcomes and renal thresholds
FULL ACCESS — £14.99/year unlocks:
— GLP-1 Receptor Agonists: semaglutide, liraglutide, dulaglutide, tirzepatide
— DPP-4 Inhibitors: sitagliptin, linagliptin, alogliptin, vildagliptin
— Metformin: doses, eGFR thresholds, B12 monitoring
— Sulfonylureas: gliclazide, glipizide, glibenclamide
— Insulin: basal, bolus, premixed, ultra-long analogues
— Thiazolidinediones, Meglitinides, Alpha-glucosidase inhibitors
— Prescribing Guide: renal dosing table, contraindications, monitoring
— HbA1c Targets: individualised targets by patient group
— CV Outcomes Trials: EMPA-REG, LEADER, DECLARE, DAPA-HF, REWIND, SURPASS
— Hypoglycaemia Management: severity grading, treatment protocol
— Sick Day Rules: SADMAN, JBDS inpatient protocol
— Special Situations: pregnancy, CKD, elderly, perioperative
— References: 25+ tappable citations, NICE, NEJM, Lancet, ADA
Subscription renews automatically at £14.99/year unless cancelled at least 24 hours before the end of the current period. Manage in App Store Settings > Subscriptions.
For use by qualified healthcare professionals only. Always verify doses against the current BNF and SmPC before prescribing.

## Rankings

- #1,329,320 — Overall

## Similar extensions and apps

- [SGLT2 & GLP-1 in Diabetes](https://chrome-stats.com/d/id1480885616)
- [Antihypertensives](https://chrome-stats.com/d/id6764155527)
- [Cardiology Drugs Ref](https://chrome-stats.com/d/id6761285646)
- [NutriGLP](https://chrome-stats.com/d/id6758135559) — 5.00 / 5
- [ABC of Diabetes Aetiology](https://chrome-stats.com/d/id1146395591) — 5.00 / 5
- [DKA & HSS](https://chrome-stats.com/d/id6763435517)
- [Davis's Drug Guide - Nurses](https://chrome-stats.com/d/id301427093) — 4.90 / 5
- [T2D Helper](https://chrome-stats.com/d/id1311365150)
- [Diabetes - Type 2](https://chrome-stats.com/d/id6737816328)
- [Vivanos Health](https://chrome-stats.com/d/id6443836556) — 5.00 / 5
- [ADA Standards of Care](https://chrome-stats.com/d/id529516990) — 4.90 / 5
- [GSTT Think Glucose](https://chrome-stats.com/d/id1084218676)

---

Source: [Chrome-Stats](https://chrome-stats.com/d/id6761283169)
